Abstract:
A MEMS structure includes a backplate, a membrane, and an adjustable ventilation opening configured to reduce a pressure difference between a first space contacting the membrane and a second space contacting an opposite side of the membrane. The adjustable ventilation opening is passively actuated as a function of the pressure difference between the first space and the second space.
Abstract:
The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.
Abstract:
The invention relates to a method for producing an injection valve for liquids, preferably an injection valve for injecting fuel into a combustion chamber of an internal combustion engine. The injection valve has a valve body, with a valve seat which is formed therein, and a valve needle which interacts with the valve seat in order to open and close at least one injection opening. The injection valve is produced by means of the following method steps: producing the valve body from steel, hardening the valve body, annealing a partial region of the valve body at an annealing temperature. The device for carrying out the method according to the invention has an inductive annealing generator which generates a suitable alternating current for operating a coil, in the magnetic field of which coil the valve body can be heated for annealing.
Abstract:
The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.
Abstract:
The present invention refers to a method of diagnosis of a predisposition to develop thrombotic disease, to test systems and their use for the diagnosis of a predisposition to develop thrombotic disease, to a P2X1 promoter variant and its use for screening for an anti-thrombotic agent, and to methods for identifying an individual that can be prophylactically or therapeutically treated with an anti-thrombotic agent, or for adapting a therapeutic or prophylactic dose of an anti-thrombotic agent.
Abstract:
Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases in which high blood platelet aggregations occur.
Abstract:
The circuit arrangement includes a first low-pass filter (2) for filtering an input signal (H3) proportional to the strength of a received radio signal; a second low-pass filter (3) for filtering the input signal (H3); a first weighting circuit (7) for weighting the first low-pass filter output signal with first coefficients to form a first weighted output signal; a circuit device for forming a masking signal for reducing stereo channel isolation from the first weighted output signal; a second weighting circuit (5) for forming a second weighted output signal weighted with second coefficients from the first low-pass filter output signal or the second low-pass filter output signal according to a switching signal (DD2) indicative of interference in the audio signals; a switch device (4) for selecting the first low-pass filter output signal for weighting in the second weighting circuit means (5) when no interference is indicated by the switching signal (DD2) and the second low-pass filter output signal for weighting in the second weighting circuit means (5) when interference is indicated by the switching signal (DD2); and a circuit device for forming a masking signal for damping the audio signal from the second weighted output signal.
Abstract:
A radio receiver is provided having digital signal processing, a first and a second auxiliary signal derived from a received stereo multiplex signal, the first auxiliary signal being dependent upon the existence of signal components, whose frequency lies above the fundamental frequency range of the stereo multiplex signal, and the second auxiliary signal being dependent upon the symmetry of the sidebands of the stereo subcarrier. The first and the second auxiliary signal are combined to form an interference signal indicating the existence of interference. At least one control signal is derived from the interference signal to influence the audio signals acquired by decoding the stereo multiplex signal.
Abstract:
In a circuit for digital processing of audio signals in a radio receiver, preferably in a car radio, the audio signals pass through a digital filter designed as a tone control, whose frequency response can be controlled with supplied coefficients, and a volume control, whose transmission factor can be controlled with supplied control signals. If the high and/or low frequencies are raised, the transmission factor of the filter at medium frequencies can be correspondingly lowered. Volume control compensates for the reduction. The volume control may contain a digital and an analog portion.
Abstract:
The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, R9, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.